Evidence map›Paper›PMID 42318948›Full record

ArticleAlimentary pharmacology & therapeutics2026

Letter: A Histology-Defined Triple-Negative Phenotype of Primary Biliary Cholangitis.

Shasha Li, Yu Zhang, Yuxiang Gong, Xueyan Li, Yulin Tao, Yiting Wang, Yongfeng Yang

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Alimentary pharmacology & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shasha LiDepartment of Infectious Disease and Liver Disease, Nanjing Key Laboratory of Hepatology, The Second Hospital of Nanjing, Clinical Teaching Hospital of Medical School, Nanjing University, Nanjing, China.ORCID https://orcid.org/0000-0003-3983-2915
Yu ZhangDepartment of Infectious Disease and Liver Disease, Nanjing Key Laboratory of Hepatology, The Second Hospital of Nanjing, Affiliated to Nanjing, University of Chinese Medicine, Nanjing, China.
Yuxiang GongDepartment of Infectious Disease and Liver Disease, Nanjing Key Laboratory of Hepatology, The Second Hospital of Nanjing, Affiliated to Nanjing, University of Chinese Medicine, Nanjing, China.
Xueyan LiDepartment of Infectious Disease and Liver Disease, Nanjing Key Laboratory of Hepatology, The Second Hospital of Nanjing, Clinical Teaching Hospital of Medical School, Nanjing University, Nanjing, China.
Yulin TaoDepartment of Infectious Disease and Liver Disease, Nanjing Key Laboratory of Hepatology, The Second Hospital of Nanjing, Affiliated to Nanjing, University of Chinese Medicine, Nanjing, China.
Yiting WangDepartment of Infectious Disease and Liver Disease, Nanjing Key Laboratory of Hepatology, The Second Hospital of Nanjing, Affiliated to Nanjing, University of Chinese Medicine, Nanjing, China.
Yongfeng YangDepartment of Infectious Disease and Liver Disease, Nanjing Key Laboratory of Hepatology, The Second Hospital of Nanjing, Clinical Teaching Hospital of Medical School, Nanjing University, Nanjing, China.ORCID https://orcid.org/0000-0002-3214-0038

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42318948
PMCPMC13466164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.